|
APBB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.388000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.310000E-01 |
| Normal-vs-Stage2 |
4.376600E-04 |
| Normal-vs-Stage3 |
2.07009999997343E-06 |
| Normal-vs-Stage4 |
1.39079999994518E-06 |
| Stage1-vs-Stage2 |
4.265000E-03 |
| Stage1-vs-Stage3 |
2.557400E-04 |
| Stage1-vs-Stage4 |
9.55129999999915E-05 |
| Stage2-vs-Stage3 |
7.644000E-01 |
| Stage2-vs-Stage4 |
6.615000E-01 |
| Stage3-vs-Stage4 |
3.582800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.388200E-04 |
| Normal-vs-AfricanAmerican |
1.748550E-01 |
| Normal-vs-Asian |
8.343400E-01 |
| Caucasian-vs-AfricanAmerican |
8.936600E-01 |
| Caucasian-vs-Asian |
5.293800E-01 |
| AfricanAmerican-vs-Asian |
7.139000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.844700E-04 |
| Normal-vs-Female |
2.296900E-03 |
| Male-vs-Female |
9.291400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.369600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.375560E-02 |
| Normal-vs-Age(61-80Yrs) |
6.006900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.880010E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.505800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.133800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.098000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.476600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.888200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.151000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.435550E-01 |
| Normal-vs-Grade 2 |
4.464800E-01 |
| Normal-vs-Grade 3 |
4.98040000351807E-08 |
| Normal-vs-Grade 4 |
3.34020000003488E-06 |
| Grade 1-vs-Grade 2 |
7.386000E-02 |
| Grade 1-vs-Grade 3 |
8.797500E-03 |
| Grade 1-vs-Grade 4 |
1.190660E-04 |
| Grade 2-vs-Grade 3 |
2.04459999999518E-05 |
| Grade 2-vs-Grade 4 |
1.639400E-04 |
| Grade 3-vs-Grade 4 |
5.235400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.250300E-02 |
| Normal-vs-ccB subtype |
2.827600E-02 |
| ccA subtype-vs-ccB subtype |
5.518600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43379999999416E-05 |
| Normal-vs-N1 |
1.143160E-03 |
| N0-vs-N1 |
5.169800E-02 |
|
|
